A randomized, open-label, single oral dose, two-way crossover study comparing safety and pharmacokinetics of HCP1401 (amlodipine/losartan potassium/chlorthalidone) with a loose combination of HCP0605 (amlodipine/losartan potassium) and HGP1405 (chlorthalidone) in healthy subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 29 Mar 2018

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Amlodipine/chlortalidone/losartan (Primary) ; Amlodipine/losartan; Chlortalidone
Indications Hypertension
Focus Adverse reactions; Pharmacokinetics

Most Recent Events

29 Mar 2018 New trial record
24 Mar 2018 Results presented at the 119th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Login with a username/password associated to an account with a valid subscription
Contact your organization’s admin about adding this content to your AdisInsight subscription
Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Welcome to AdisInsight